Nakamura Yuichi, Nakazato Hiroshi, Sato Yuko, Furusawa Shinpei, Mitani Kinuko
Department of Hematology, Dokkyo University School of Medicine, Tochigi, Japan.
Am J Hematol. 2002 Jan;69(1):80-2. doi: 10.1002/ajh.10028.
The t(3;12)(q26;p13) translocation is a recurrent chromosomal aberration observed in myeloid malignancies. It has been shown that the translocation results in the fusion of the TEL (ETV6) gene at 12p13 and the EV11 gene at 3q26. We report the first case with Philadelphia (Ph)-positive chronic myelogenous leukemia (CML) expressing the TEL/EVI1 fusion transcript. A 26-year-old man was initially diagnosed as having the chronic phase of Ph-positive CML. The t(3;12)(q26;p13) emerged 16 months prior to the myeloid blastic crisis. Reverse transcriptase-polymerase chain reaction detected the TEL/EVI1 transcript without the intervening 5' non-coding exon of EVI1, suggesting that inappropriate expression of the EVI1 protein driven by the TEL promotor could play a critical role in progression to the blast crisis of CML.
t(3;12)(q26;p13)易位是在髓系恶性肿瘤中观察到的一种常见染色体畸变。已表明该易位导致位于12p13的TEL(ETV6)基因与位于3q26的EV11基因融合。我们报告了首例表达TEL/EVI1融合转录本的费城(Ph)阳性慢性髓性白血病(CML)病例。一名26岁男性最初被诊断为处于Ph阳性CML慢性期。t(3;12)(q26;p13)在髓系原始细胞危象前16个月出现。逆转录酶-聚合酶链反应检测到TEL/EVI1转录本,其中没有EVI1中间的5'非编码外显子,这表明由TEL启动子驱动的EVI1蛋白的不适当表达可能在CML进展为原始细胞危象中起关键作用。